AID Life Science Holdings Limited reported group earnings guidance for the six months ended 30 June 2018. The group is expected to record a significant decrease in loss for the six months ended 30 June 2018 as compared to that for the six months ended 30 June 2017, which was mainly attributable to unrealized fair value loss recognized upon the reclassification of the investment from the interest in an associate to the financial assets at fair value through profit or loss during the six months ended 30 June 2017, whereas no such loss was recognized for the Period.